Similar findings were reported in breast cancer and hepatocellular carcinoma; KRT19 expression correlated with poor prognosis in breast cancer (56) and predicted early postoperative recurrence in hepatocellular carcinoma (57). Here, KRT19 is linked to breast cancer.